|
Original Artikel |
Datum |
Titel |
Autoren Alle Autoren |
1 |
[GO] |
2025―Mrz―15 |
Evaluation of enisamium iodide’s impact on the clinical course of acute respiratory viral infections, influenza and COVID-19 in outpatients |
O.A. Golubovska, K.O. Chalyу, O.V. Bezrodna, А.О. Golubovska, еt Al. |
2 |
[GO] |
2024―Aug―29 |
Cerebral venous hemodynamics in patients who had COVID-19 with and without psychiatric disorders |
R.Ya. Аbdullaiev, V.V. Nikonov, I.V. Leshchyna, F.I. Kulikova, A.G. Kyrychenko, A.G. Sirko, et al. (+2) S.O. Dudukina, N.V. Tomakh |
3 |
[GO] |
2024―Jul―02 |
Venous thrombosis and embolism in surgical hospital patients in the conditions of the COVID-19 pandemic |
B.O. Matviychuk, N.R. Fedchyshyn, R.L. Bokhonko |
4 |
[GO] |
2024―Apr―30 |
Prognostic properties of biomarkers in COVID-19 infection and concomitant chronic coronary syndromes |
I.V. Tomyn, S.V. Fedorov |
5 |
[GO] |
2024―Apr―18 |
The possibility of predicting the occurrence of neurological complications in patients with COVID-19 |
K.V. Yurko, H.O. Solomennik, V.V. Kucheriavchenko, O.Y. Bondar, V.M. Kozko, A.S. Liesna, A.М. Bilovol |
6 |
[GO] |
2023―Nov―12 |
Hematological disorders as a complication of COVID-19 |
Yu.I. Markov, I.A. Markova, N.V. Goriainova, B.M. Kuiavovych |
7 |
[GO] |
2023―Nov―12 |
The influence of air pollutants on COVID-19 severity in the administrative and industrial city of Kharkiv |
A.P. Podavalenko, M.A. Georgiyants, O.V. Vysotska, O.M. Korzh, A.P. Porvan, V.S. Maslova, et al. (+2) V.I. Bereznyakov, O.I. Babaieva |
8 |
[GO] |
2023―Nov―12 |
Pandemics and their geographical distribution |
N. Komilova, N. Mukhammedova, N. Ermatova, Z. Ibragimova, S. Bafoeva |
9 |
[GO] |
2023―Sep―11 |
Pathomorphological changes in the lungs in severe COVID-19 |
O.K. Yakovenko, S.L. Griff, S. Hoffmann, О.H. Khanin, E.M. Khodosh, Ya.О. Dziublyk |
10 |
[GO] |
2023―Jun―25 |
COVID-19 and non-steroid anti-inflammatory drugs |
O.A. Loskutov, M.V. Bondar, G.M. Bondar |
11 |
[GO] |
2023―Jun―25 |
Studying the effectiveness of varieties of anticoagulant therapy programs in patients with a severe course of COVID-19 (analysis of own clinical observations) |
O.M. Mazur, M.V. Bondar |
12 |
[GO] |
2022―Dez―28 |
Effectiveness of the immunomodulator thymalin in experimental coronavirus infection |
M.M. Kozlovsky |
13 |
[GO] |
2022―Sep―25 |
Панель Surviving Sepsis Campaign COVID-19 |
Yu.Yu. Kobelyatskyy, L.A. Maltseva, I.A. Maltsev, V.N. Lisnichaya, N.A. Kazimirova |
14 |
[GO] |
2022―Jun―29 |
Тромбоемболічні ускладнення у хворих з гострою хірургічною патологією при коронaвірусній інфекції COVID-19 |
V.V. Boyko, V.M. Likhman, O.M. Shevchenko, O.Y. Tkachuk, A.O. Merkulov, E.O. Belodyd, K.V. Ponomarova |
15 |
[GO] |
2022―Jun―29 |
Клінічний випадок пролонгованої СРАР-вентиляції у пацієнтки з COVID-19-асоційованою пневмонією |
A.P. Mazur, O.Yu. Khomenko, A.O. Borysenko, E.I. Novikova |
16 |
[GO] |
2022―Jun―29 |
Клінічні та гістопатофізіологічні особливості дифузного альвеолярного ураження (пневмонії), обумовленого SARS-CoV-2, у хворих, які потребують респіраторної підтримки |
E.M. Khodosh, I.V. Ivakhno |
17 |
[GO] |
2022―Mai―19 |
COVID-19 і сепсис: клінічні паралелі особливостей перебігу та напрямки лікування |
I.A. Kuchynska, V.M. Bogomaz, O.A. Halushko, A.O. Sydorova, A.H. Andriukhov, V.P. Romanyuk, L.I. Antoniuk |
18 |
[GO] |
2022―Mai―19 |
Патогенетична терапія COVID-19: у центрі уваги глюкокортикоїди |
M.V. Bondar, M.M. Pilipenko, T.V. Ovsiienko, O.A. Loskutov |
19 |
[GO] |
2022―Mai―13 |
Оцінка перебігу коагулопатій, пов’язаних із COVID-19, у пацієнтів з хірургічною патологією |
V.V. Boyko, V.M. Likhman, O.M. Shevchenko, O.Yu. Tkachuk, A.O. Merkulov, S.V. Tkach, et al. (+2) D.O. Miroshnichenko, K.V. Ponomarova |
20 |
[GO] |
2021―Dez―08 |
Features of clinical manifestations of new coronavirus infection in patients at hospitalization during the COVID-19 epidemic depending on the severity |
V.I. Trykhlib, N.R. Tsiurak, K.P. Beliaeva, T.I. Lysenko, A.O. Yeroshenko, O.S. Martynchyk |
21 |
[GO] |
2021―Dez―03 |
Peculiarities of clinical manifestations of the new COVID-19 coronavirus infection in patients hospitalized during the epidemic depending on their age |
V.I. Trykhlib, N.R. Tsiurak, K.P. Beliaeva, T.I. Lysenko, A.O. Yeroshenko, O.S. Martynchyk |
22 |
[GO] |
2021―Okt―29 |
Multisystem inflammatory syndrome in children аssociated with COVID-19 |
I.I. Gorelkin, V.N. Kapusta, I.A. Buinyi, E.V. Bachtina, S.A. Zhmychova |
23 |
[GO] |
2021―Okt―13 |
The effect of intravenous immunoglobulin on the course of acute respiratory disease COVID-19. Own observations |
M.V. Mokina, O.D. Melnyk |
24 |
[GO] |
2021―Aug―20 |
New coronavirus disease (COVID-19): symptoms, laboratory blood indicators in the critically ill and dead patients |
V.I. Trykhlib, A.P. Kazmirchuk, V.V. Grushkevych, T.V. Burakova |
25 |
[GO] |
2021―Aug―20 |
Clinical and laboratory manifestations in critically ill patients with COVID-19 and deceased people |
V.I. Trykhlib, T.I. Lysenko, A.O. Yeroshenko, О.S. Martynchyk, K.P. Bieliaieva, N.R. Tsiurak, et al. (+16) S.O. Nevmerzhytsky, V.V. Hrushkevych, O.I. Samoilenko, O.V. Kulova, Yu.I. Danylenko, V.I. Lysko, Yu.O. Boklan, T.V. Burakova, I.V. Chub, O.Kh. Nasibullin, T.I. Shevelova, S.S. Popova, S.M. Samoilova, S.M. Chaika, O.S. Holubenko, А.V. Moroz |
26 |
[GO] |
2021―Aug―20 |
Main causes of complicated COVID-19 in patients with diabetes mellitus |
O.A. Halushko, O.A. Loskutov, M.A. Trishchynska, I.A. Kuchynska, M.V. Boliuk |
27 |
[GO] |
2021―Jun―26 |
Multiple-organ failure in patients with severe coronavirus disease (COVID-19) |
I.A. Kuchynska, B.O. Savchenko, A.H. Andriukhov, A.M. Ivanchenko, N.V. Astashkina, Ye.O. Hulevatyi, U.L. Kashchii |
28 |
[GO] |
2021―Jun―26 |
Peculiarities of intensive care for pregnant and postpartum women with severe course of coronavirus disease (COVID-19) |
N.V. Matolinets, O.O. Samchuk, S.I. Hlukhovska, K.Z. Zhyvitska |
29 |
[GO] |
2021―Jun―26 |
Features of intensive care of patients with diabetic ketoacidosis during the pandemic COVID-19 |
O.A. Halushko, I.A. Kuchynska, S.I. Babak, V.V. Yurkiv, L.V. Antonyuk, M.V. Kushnyr |
30 |
[GO] |
2021―Jun―26 |
COVID-19: cytokine storm and anticytokine therapy |
M.V. Bondar, M.M. Pylypenko, O.A. Loskutov |
31 |
[GO] |
2021―Apr―19 |
Possibilities of managing pulmonary hypertension in patients with severe acute respiratory distress syndrome caused by COVID-19 |
V.A. Korsunov, V.S. Skoryk |
32 |
[GO] |
2020―Aug―27 |
Review of the international guidelines for nutritional support in patients with COVID-19 in the intensive care unit |
Yu.Yu Kobelyatskyi |